Monday 14 July 2014 10:00 - 12:30
Track 2 - New drug research and development for Alzheimer's disease

Chair: Lin Li

Dl-PHPB, a novel drug candidate for Alzheimer's disease
Xiaoliang Wang

Beneficial effects of huperzine A on mitochondrial dysfunction and potential molecular mechanisms
Haiyan Zhang

Combinational therapeutic targets for Alzheimer's disease based on network pharmacology
Wenxia Zhou

Multitarget strategy and new drug development of traditional Chinese medicine to treat Alzheimer's disease
Lin Li

 

South African Society for Basic and Clinical Pharmacology Section 21 Company, Registration no. 2006/029963/08 Registry Office: Alchemy Financial Services Unit 3 Bush Hill Office Park, Jan Frederick Ave, Honeydew 2154

© Scatterlings Conference and Events